Prague Med. Rep. 2012, 113, 58-65
https://doi.org/10.14712/23362936.2015.38
Heart Failure Treated with Low-dose Milrinone in a Full-term Newborn
References
1. Alpan, G. (2009) Persistent pulmonary hypertension of the newborn. In: Neonatology: Management, Procedures, On-Call Problems, Diseases and Drugs, 6th Edition. Gomella, T. L., Cunningham, M. D., Eyal, F. G., Tuttle, D., pp. 636–644, McGraw-Hill, New York.
2. Anderson, A. L. (2009) Commonly used medications. In: Neonatology: Management, Procedures, On-Call Problems, Diseases and Drugs, 6th Edition. Gomella, T. L., Cunningham, M. D., Eyal, F. G., Tuttle, D., pp. 729–787, McGraw-Hill, New York.
3. , D., Choong, K., McNamara, P., Kirpalani, H. (2006) Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol. Neonate 89(1), 1–5.
<https://doi.org/10.1159/000088192>
4. Bassler, D., Kreutzer, K., McNamara, P., Kirpalani, H. (2010) Milrinone for persistent pulmonary hypertension of the newborn. Cochrane Database Syst. Rev. 10(11), CD007802.
5. , B., Josephson, C., Fackler, J. (2007) Oxygenation index for extracorporeal membrane oxygenation: is there predictive significance? J. Artif. Organs 10(1), 6–9.
<https://doi.org/10.1007/s10047-006-0359-7>
6. , A. R., Meliones, J. N. (1998) Cardiogenic shock. New Horiz. 6(2), 139–149.
7. , P., Craig, N. (2009) Extracorporeal membrane oxygenation for neonatal respiratory failure. Respir. Care 54(9), 1244–1251.
<https://doi.org/10.4187/002013209793800402>
8. , B., Lakshminrusimha, S., Czech, L., Groh, B. S., Gugino, S. F., Russel, J. A. (2009) Regulation of phosphodiesterase 3 in the pulmonary arteries during the perinatal period in sheep. Pediatr. Res. 66(6), 682–687.
<https://doi.org/10.1203/PDR.0b013e3181bce574>
<PubMed>
9. , O., Margossian, R., Geva, T., Kourembanas, S. (2005) Pulmonary hypertension and right ventricular dysfunction in growth-restricted, extremely low birth weight neonates. J. Perinatol. 25, 495–499.
<https://doi.org/10.1038/sj.jp.7211299>
10. Greenough, A., Milner, A. D. (2005) Pulmonary disease of the newborn: Acute respiratory disease. In: Roberton’s Textbook of Neonatology, 4th Edition. Rennie, J. M., Elsevier, London.
11. , T. M., Wernovsky, G., Atz, A. M., Kulik, T. J., Nelson, D. P., Chang, A. C., Bailey, J. M., Akbary, A., Kocsis, J. F., Kaczmarek, R., Spray, T. L., Wessel, D. L. (2003) Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107(7), 996–1002.
<https://doi.org/10.1161/01.CIR.0000051365.81920.28>
12. , D. T., Pearson, G. D. (2009) Heart failure in children: part I: history, etiology, and pathophysiology. Circ. Heart Fail. 2(1), 63–70.
<https://doi.org/10.1161/CIRCHEARTFAILURE.108.820217>
13. Kinsella, J. P. (2006) Inhaled nitric oxide therapy. In: Manual of Neonatal Respiratory Care, 2nd Edition. Donn, S. M., Sinha, S. K., pp. 426–427, Mosby, Philadelphia.
14. , C. J., Murchan, H., Prendiville, T., Burch, M. (2006) Long-term support with milrinone prior to cardiac transplantation in neonate with left ventricular noncompaction cardiomyopathy. Pediatr. Cardiol. 28(4), 317–318.
<https://doi.org/10.1007/s00246-007-0020-0>
15. , P., Laique, F., Muang, S., Whyte, H. (2006) Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J. Crit. Care 21(2), 217–222.
<https://doi.org/10.1016/j.jcrc.2006.01.001>
16. , M., Jiang, X., McLachlan, A. J., Evans, N., Kluckow, M., Osborn, D. (2007) Population pharmacokinetics and dosing regimen design of milrinone in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 92(3), F204–F209.
<https://doi.org/10.1136/adc.2005.092817>
<PubMed>
17. , M., Evans, N., Kluckow, M., Osborn, D. (2009) Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. J. Pediatr. 154(2), 189–195.
<https://doi.org/10.1016/j.jpeds.2008.07.059>
18. , S. T., Grupp, I., Grupp, G., Matlib, M. A., Solaro, R. J., Schwartz, A. (1986) Myocardial actions of milrinone: characterization of its mechanism of action. Circulation 73(3), 134–144.
19. , A. (2011) Haemodynamically unstable preterm infant: an unresolved management conundrum. Eur. J. Pediatr. 170(10), 1237–1245.
<https://doi.org/10.1007/s00431-011-1435-4>
20. , A., Francis, J. V., Lewis, A. I. (2011) Use of milrinone in the management of haemodynamic instability following duct ligation. Eur. J. Pediatr. 170(10), 115–119.
<https://doi.org/10.1007/s00431-010-1296-2>
21. , S. A., Liu, Y. (2010) Pulmonary hypertension of the newborn. Best Pract. Res. Clin. Anaesthesiol. 24(3), 375–386.
<https://doi.org/10.1016/j.bpa.2010.02.021>
22. , H., Tajimi, K., Moritsune, O., Kobayashi, K., Okada, K. (1991) Effects of milrinone on pulmonary vasculature in normal dogs and in dogs with pulmonary hypertension. Crit. Care Med. 19(1), 68–74.
<https://doi.org/10.1097/00003246-199101000-00017>
23. , C., Cerbo, R. M., Perotti, G., Stronati, M. (2010) Persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide-treated with milrinone: a case report. Turk. J. Pediatr. 52(1), 78–80.
24. , A. F., Nicolson, S. C., Adamson, P. C., Wernovsky, G., Mondick, J. T., Burnham, N., Hoffman, T. M., Gaynor, J. W., Davis, L. A., Greeley, W. J., Spray, T. L., Barrett, J. S. (2006) Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction. Anesth. Analg. 102(4), 1062–1069.
<https://doi.org/10.1213/01.ane.0000198626.67391.34>
